Marco Sanduzzi‐Zamparelli

Author

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer ORCID

Also Known As

M Sanduzzi-Zamparelli, M. Sanduzzi-Zamparelli, Marco Sanduzzi-Zamparelli, Marco Sanduzzi‐Zamparelli

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Hospital Clínic de Barcelona Universitat de Barcelona Inserm

About

Marco Sanduzzi‐Zamparelli is an author at Consorci Institut D'Investigacions Biomediques August Pi I Sunyer specializing in pathology, medicine, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	245
2	Hepatology	5	5	245
3	Pathology	5	5	245
4	Public Health	1	1	73
5	Epidemiology	1	1	73

Marco Sanduzzi‐Zamparelli

Publications

517

Citations

H-Index

Page 1

	Year	Citations
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation Massimo Iavarone, Federica Invernizzi, Carolin Czauderna, American Journal of Transplantation	2019	85
International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance Amit G. Singal, Marco Sanduzzi‐Zamparelli, Pierre Nahon, Journal of Hepatology EpidemiologyCancer RiskHepatologyCancer EpidemiologyMedicine	2023	73
Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection Carla Fuster, Ezequiel Mauro, Joana Ferrer, Journal of Hepatology Liver ResectionSurgical OncologyHepatologyMedicineHistopathology	2024	72
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours Ignacio Melero, María de Miguel Luken, Guillermo de Velasco, Nature	2024	68
Assessing the impact of COVID-19 on liver cancer management (CERO-19) Sergio Muñoz, Víctor Sapena, Alejandro Forner, JHEP Reports	2021	60
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules Marco Sanduzzi‐Zamparelli, Zoe Mariñó, Sabela Lens, Journal of Hepatology Hepatitis DHepatologyAdvanced Liver DiseaseViral HepatitisMedicine	2021	41
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study Massimo Iavarone, Federica Invernizzi, Tommy Ivanics, Liver Transplantation Regorafenib EfficacyHcc RecurrenceTransplantationOncologyHepatology	2021	34
Hepatic epithelioid hemangioendothelioma: An international multicenter study Marco Sanduzzi‐Zamparelli, Jordi Rimola, Carla Montironi, Digestive and Liver Disease HepatologyLiver PhysiologyHepatobiliary TumorHistopathologyPathology	2020	25
Outcome of liver cancer patients with SARS‐CoV‐2 infection: An International, Multicentre, Cohort Study Sergio Muñoz, Víctor Sapena, Alejandro Forner, Liver International	2022	21
International and multicenter real‐world study of sorafenib‐treated patients with hepatocellular carcinoma under dialysis Álvaro Díaz‐González, Marco Sanduzzi‐Zamparelli, Leonardo Gomes da Fonseca, Liver International	2020	17

Page 1